ONWARD: 1-year ARC-EX Therapy unlocks additional recovery in SCI
This morning, ONWARD Medical shared a publication detailing supportive results from an independent, investigator-sponsored Pathfinder2 study, further building the clinical evidence for ARC-EX's therapeutic potential to restore function in SCI patients. While the Up‑LIFT study demonstrated groundbre
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.